MAR 31, 2020 9:00 AM PDT

Impact of liquid biopsy in advanced HER2+ breast cancer tumors: a follow-up study

Speaker

Abstract
DATE:  March 31, 2020
TIME:  9:00am PT, 12:00pm ET
 
HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2 (HER2). While this aggressive breast cancer is highly curable, with 10 year survival rates at an average of >70%, it is also highly prevalent – with this gene mutation being detected in 1 out of every 5 breast cancer cases. In addition to chemotherapy, there are multiple targeted therapies approved for treatment of HER2+ breast cancer. However, HER2+ breast cancer also has a high recurrence rate, increasing the chances of the cancer metastasizing.
 
In today's presentation, Dr. Allegretti will discuss his clinical research work on HER2+ metastatic breast cancer samples using liquid biopsy (LB) analysis. This study aims to determine feasibility of profiling and tracking over time the molecular behavior of advanced HER2+ breast cancer tumors during drug treatments. Analysis is conducted using two different LB techniques - next-generation sequencing (NGS) and digital PCR (dPCR). Results strongly encourage the integration of LB analysis with genomic assessment from tumor tissues. Together, these complementary techniques may be able to provide compelling evidence to uncover resistance/response mechanisms in the future, potentially yielding valuable clinical information for better cancer management strategies.
 
Learning Objectives:
  • Investigate advantages of analyzing advanced HER2+ metastatic breast cancer tumor samples with Liquid Biopsy 
  • Demonstrate the complementary nature of dPCR and NGS Liquid Biopsy analysis
  • Illustrate the advantages of combined tissue biopsy and Liquid Biopsy analyses
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
Loading Comments...
Show Resources
Attendees
  • See more